NCT00571922View on ClinicalTrials.gov

A Clinical Trial of Acamprosate for Treatment of Methamphetamine Addiction

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Methamphetamine Dependence, Treatment Seeking
Interventions
DRUG

Acamprosate

2 gr/day (333 mg, TID)

DRUG

placebo

matching placebo

Trial Locations (1)

10010

VA New York Harbor Healthcare System, MHAD clinic, New York

Sponsors

Collaborators (1)

Forest Laboratories
All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

NYU Langone Health

OTHER